SC1-BHC-08-2020
SC1-BHC-08-2020
12 projects · €74,968,293 total EU contribution (project-level) · 160 participating organizations · 23 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€74,968,293
Countries active
Participant organizations by country (headquarters in CORDIS).
- Spain (32)
- Germany (23)
- France (15)
- Italy (14)
- Netherlands (13)
- BE (10)
- UK (9)
- CH (6)
- CZ (6)
- AT (5)
- DK (4)
- SE (3)
- US (3)
- IE (2)
- IL (2)
- PL (2)
- PT (2)
- RO (2)
- RS (2)
- SI (2)
- FI (1)
- NO (1)
- TR (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- CHARITE - UNIVERSITAETSMEDIZIN BERLIN4 projects · DE
- Leiden University Medical Center3 projects · NL
- Institut klinické a experimentální mediciny3 projects · CZ
- MEDICAL UNIVERSITY OF GRAZ3 projects · AT
- SERMAS3 projects · ES
- STICHTING AMSTERDAM UMC3 projects · NL
- UNIVERSITEIT MAASTRICHT3 projects · NL
- AUH2 projects · DK
- ASSISTANCE PUBLIQUE HOPITAUX DE PARIS2 projects · FR
- CNIC2 projects · ES
- CONCENTRIS RESEARCH MANAGEMENT GMBH2 projects · DE
- IMIM2 projects · ES
Projects
Page 1 of 2
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
PERSONALISATION OF IMMUNOSUPPRESSION BY MONITORING VIRAL LOAD POST KIDNEY TRANSPLANTATION - A RANDOMISED CONTROLLED PHASE II TRIAL TTV GUIDE TX · 896932 | H2020 | €6,099,831 | €722,269 | Details |
Clinical validation of a continuous flow peritoneal dialysis system, with dialysate regeneration CORDIAL · 945207 | H2020 | €3,482,225 | €486,074 | Details |
PCOS IN ADOLESCENT GIRLS AND YOUNG WOMEN: TOWARD A TREATMENT GUIDED BY PATHOPHYSIOLOGY SPIOMET4HEALTH · 899671 | H2020 | €6,366,149 | €2,141 | Details |
Ground-BrEAking Electroporation-based inTervention for Atrial Fibrillation treatment (BEAT AF) BEAT AF · 945125 | H2020 | €6,093,743 | €216,250 | Details |
Remote Ischemic Conditioning in Lymphoma Patients Receiving Anthracyclines. RESILIENCE · 945118 | H2020 | €5,998,388 | €378,729 | Details |
A New Intervention for Implementation of Pharmacogenetics in Psychiatry PSY-PGx · 945151 | H2020 | €7,999,612 | €798,461 | Details |
Proof of Principle of the best-in-class therapeutic mRNA cancer vaccine TIGER · 945011 | H2020 | €6,900,000 | €186,188 | Details |
Improving COgnition in Down syndrome ICOD · 899986 | H2020 | €5,989,840 | €292,500 | Details |
A PROSPECTIVE EUROPEAN VALIDATION COHORT FOR STEREOTACTIC THERAPY OF RE-ENTRANT TACHYCARDIA STOPSTORM · 945119 | H2020 | €7,161,437 | €218,657 | Details |
Rituximab in patients with acute myocardial infarction: a phase 2 placebo-controlled randomised clinical trial RITA-MI 2 · 899991 | H2020 | €6,583,216 | €314,000 | Details |